Home » Drug Information » FDA Approved Drugs » 1999
Medical Areas: Pediatrics/Neonatology
View By:YearCompanyConditionsTherapeutic AreasDrug Names
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: SmithKline Beecham
Approval Status: Approved July 1999
Treatment Area: Pediatrics
Amoxil, previously given three times a day to pediatric
patients, is now available for twice daily dosing. Eliminating the
middle dose will make it easier for patients to administer the
medicine, as they will no longer have to worry about whether that
dose will be given during daycare or school hours. Studies show
that, among all types of medications, compliance is generally
improved by decreasing the required number of daily doses.
Amoxil is highly active in vitro against Step. Pneumoniae and
other common bacteria. It is used primarily as a first-line
antibiotic for upper and lower respiratory tract infections. Amoxil
can be taken with or without food.
Adverse events include diarrhea and nausea. Amoxil is
contraindicated in patients with a history of allergic reaction to
any of the penicillins.